Now that his adult sons manage their own hemophilia care, columnist Joe MacDonald wonders how he can best support them.

Altuvoct (efanesoctocog alfa) was approved in the U.K. as a treatment for patients with moderate or severe hemophilia A ages ...

Columnist G Shellye Horowitz shares her approach to dating with chronic illness, particularly regarding when to discuss ...

Embracing disability identity is about acknowledging real challenges and advocating for rights, columnist Alliah Czarielle argues.

Four years after receiving Hemgenix in a Phase 3 trial, bleeding rates and the use of replacement therapy are low for men ...